Yidu Technology (02158)'s 10th repurchase since December continues to convey confidence in development

The Zhitong Finance App learned that on December 18, Yidu Technology (02158) issued its 10th repurchase announcement since this month. On the same day, 190,000 shares were repurchased at a price of HK$5.13 per share, with a repurchase amount of about HK$1 million. Since December, a total of 3.34 million shares have been repurchased, with a total amount of about HK$17 million. High-frequency and continuous repurchase operations demonstrate the company's firm confidence in intrinsic value and long-term development.

Recently, Yidu Technology has been making frequent moves in terms of business expansion and industry co-construction, and news of favorable fundamentals continues. The company officially joined the Health and Sustainable Development Working Committee established under the Shanghai Cooperation Organization Economic and Trade Platform, and will participate more in promoting cooperation and innovation in the field of health care within an international framework. In the domestic market, the number of participants in “Beijing Inclusive Health Insurance” in 2026, with Yidu Technology as the main operator, has surpassed the 3 million mark, demonstrating its strong operational capability and market recognition in the Huimin Insurance business. At the same time, the company was recently elected as the deputy chairman of the Smart Healthcare Working Committee of the China Internet Association, further consolidating its influence and technical leadership in the industry.

While the business is progressing steadily, the company's financial health is showing positive signs of improvement. According to the previously announced mid-term results for the 2026 fiscal year, Yidu Technology's revenue maintained steady growth, and almost achieved break-even during the period. The significant optimization of this key financial indicator is mainly due to the continuous increase in the gross margin of the company's core business and the continuous improvement of operational efficiency, reflecting the enhanced ability to commercialize and substantial progress in the quality of operations.

Analysts pointed out that intensive buyback practices often reflect the company's judgment on current stock price undervaluation, and also indicate that its financial strength is sufficient to support future strategic investment and sustainable development. Yidu Technology's continuous repurchases echo a series of recent developments, and together send a positive signal to the market. Under the industry trend of deep integration of artificial intelligence and medical care, Yidu Technology's long-term investment value is becoming more and more clear as the inflection point of performance approaches.